Vimarsana
Biggest News Aggregation in the World

Prime Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prime Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prime Study Today - Breaking & Trending Today

How to enrol in Neuralink's human trials? Here's your guide - Vimarsana News

How to enrol in Neuralink's human trials? Here's your guide

Dreaming of Elon Musk's brain chip? Sign up now!

Source: geo.tv
Neuralink: Neuralink has put its first chip in a human brain—What could possibly go wrong? - Vimarsana News

Neuralink: Neuralink has put its first chip in a human brain—What could possibly go wrong?

In the past few years, Neuralink has faced investigation for mistreatment of lab animals and seen the departure of several company executives. Nevertheless, the PRIME trial is a significant milestone for a company less than ten years old. However, Neuralink's challenges are far from over. Implanting a device is just the beginning of a decades-long clinical project beset with competitors, financial hurdles and ethical quandaries.

Elon Musk announces first human Neuralink implant patient, claims promising results - Vimarsana News

Elon Musk announces first human Neuralink implant patient, claims promising results

Back in May last year, Neuralink, founded by Musk in 2016, was given permission by the Federal Drug Administration (FDA) to begin its first in-human clinical study,...

Elon Musk's Neuralink implants brain chip in human - Vimarsana News

Elon Musk's Neuralink implants brain chip in human

For the first time, a human patient has received an implant from brain-chip startup Neuralink and is recovering well, the company's billionaire founder Elon Musk said.

First human implanted with brain chip by Elon Musk's Neuralink - Vimarsana News

First human implanted with brain chip by Elon Musk's Neuralink

Technology company Neuralink has implanted its brain-computer interface in a human patient for the first time as part of a clinical trial.

Source: dezeen.com